BOBCAT
LIVE

Serial Number

98207353

Owner

Elixirgen Therapeutics, Inc.

Attorney

Leonard D. Bowersox

First Use Date

Nov 6, 2024

Filing Date

Oct 3, 2023

Add to watchlist:

No watchlists yet
View on USPTO

BOBCAT Trademark

Serial Number: 98207353 • Registration: 7804750

BOBCAT is a trademark filed by Elixirgen Therapeutics, Inc. on October 3, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Elixirgen Therapeutics, Inc. (38 trademarks)

855 N. Wolfe St., Suite 624
Baltimore, MD 21205

Entity Type: 03

Trademark Details

Filing Date

October 3, 2023

Registration Date

May 20, 2025

First Use Anywhere

November 6, 2024

First Use in Commerce

November 6, 2024

Published for Opposition

July 30, 2024

Goods & Services

Pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing genetic diseases; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing infectious diseases; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing cancers; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing age-related diseases; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding ribonucleoprotein constructs for gene editing being for the treatment of genetic disorders; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding ribonucleoprotein constructs for treating genetic disorders in the nature of telomere shortening; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for regenerative medicine in the nature of cell rejuvenation

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 20, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 20, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 28, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 28, 2025 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 28, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 28, 2025 CRFA
ASSIGNED TO LIE
Apr 28, 2025 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 10, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 2, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 2, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
Apr 2, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 24, 2025 DOCK
SOU TEAS EXTENSION RECEIVED
Mar 21, 2025 EEXT
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 11, 2025 AITU
STATEMENT OF USE PROCESSING COMPLETE
Feb 10, 2025 SUPC
USE AMENDMENT FILED
Nov 27, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 27, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 24, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 30, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 30, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 10, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 21, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 20, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 20, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 29, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 29, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 29, 2024 CNRT
ASSIGNED TO EXAMINER
May 23, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 12, 2023 NWOS
NEW APPLICATION ENTERED
Oct 6, 2023 NWAP